Another study indicated a selective reduction in DARPP-32 expression in the prefrontal cortex in patients with schizophrenia, suggesting that altered expression of DARPP-32 may be associated with the development of the disease [35]. This evidence concerns the gene PPP1R1B and schizophrenia.